Access the full text.
Sign up today, get DeepDyve free for 14 days.
( Daru P, Matji R, AlMossawi HJ et al. 2018. Decentralized, community-based treatment for drug-resistant tuberculosis: Bangladesh program experience. Global Health: Science and Practice 6: 594–602.30287534)
Daru P, Matji R, AlMossawi HJ et al. 2018. Decentralized, community-based treatment for drug-resistant tuberculosis: Bangladesh program experience. Global Health: Science and Practice 6: 594–602.30287534Daru P, Matji R, AlMossawi HJ et al. 2018. Decentralized, community-based treatment for drug-resistant tuberculosis: Bangladesh program experience. Global Health: Science and Practice 6: 594–602.30287534, Daru P, Matji R, AlMossawi HJ et al. 2018. Decentralized, community-based treatment for drug-resistant tuberculosis: Bangladesh program experience. Global Health: Science and Practice 6: 594–602.30287534
(2021a)
Geocoding API Overview
( Hughes J, Snyman L. 2018. Palliative care for drug-resistant tuberculosis: when new drugs are not enough. The Lancet Respiratory Medicine 6: 251–2.29422260)
Hughes J, Snyman L. 2018. Palliative care for drug-resistant tuberculosis: when new drugs are not enough. The Lancet Respiratory Medicine 6: 251–2.29422260Hughes J, Snyman L. 2018. Palliative care for drug-resistant tuberculosis: when new drugs are not enough. The Lancet Respiratory Medicine 6: 251–2.29422260, Hughes J, Snyman L. 2018. Palliative care for drug-resistant tuberculosis: when new drugs are not enough. The Lancet Respiratory Medicine 6: 251–2.29422260
S. Abbas, M. Kermode, S. Kane (2020)
Strengthening the response to drug-resistant TB in Pakistan: a practice theory-informed approach.Public health action, 10 4
( Thomas BE, Shanmugam P, Malaisamy M et al. 2016. Psycho-socio-economic issues challenging multidrug resistant tuberculosis patients: a systematic review. PLoS One 11: e0147397.)
Thomas BE, Shanmugam P, Malaisamy M et al. 2016. Psycho-socio-economic issues challenging multidrug resistant tuberculosis patients: a systematic review. PLoS One 11: e0147397.Thomas BE, Shanmugam P, Malaisamy M et al. 2016. Psycho-socio-economic issues challenging multidrug resistant tuberculosis patients: a systematic review. PLoS One 11: e0147397., Thomas BE, Shanmugam P, Malaisamy M et al. 2016. Psycho-socio-economic issues challenging multidrug resistant tuberculosis patients: a systematic review. PLoS One 11: e0147397.
( Franke MF, Khan P, Hewison C et al. 2021. Culture conversion in patients treated with bedaquiline and/or delamanid. American Journal of Respiratory and Critical Care Medicine 203: 111–9.32706644)
Franke MF, Khan P, Hewison C et al. 2021. Culture conversion in patients treated with bedaquiline and/or delamanid. American Journal of Respiratory and Critical Care Medicine 203: 111–9.32706644Franke MF, Khan P, Hewison C et al. 2021. Culture conversion in patients treated with bedaquiline and/or delamanid. American Journal of Respiratory and Critical Care Medicine 203: 111–9.32706644, Franke MF, Khan P, Hewison C et al. 2021. Culture conversion in patients treated with bedaquiline and/or delamanid. American Journal of Respiratory and Critical Care Medicine 203: 111–9.32706644
( Van Cutsem G, Isaakidis P, Farley J et al. 2016. Infection control for drug-resistant tuberculosis: early diagnosis and treatment is the key. Clinical Infectious Diseases 62: S238–43.27118853)
Van Cutsem G, Isaakidis P, Farley J et al. 2016. Infection control for drug-resistant tuberculosis: early diagnosis and treatment is the key. Clinical Infectious Diseases 62: S238–43.27118853Van Cutsem G, Isaakidis P, Farley J et al. 2016. Infection control for drug-resistant tuberculosis: early diagnosis and treatment is the key. Clinical Infectious Diseases 62: S238–43.27118853, Van Cutsem G, Isaakidis P, Farley J et al. 2016. Infection control for drug-resistant tuberculosis: early diagnosis and treatment is the key. Clinical Infectious Diseases 62: S238–43.27118853
( Sudha G, Nirupa C, Rajasakthivel M et al. 2003. Factors influencing the care-seeking behaviour of chest symptomatics: a community-based study involving rural and urban population in Tamil Nadu, South India. Tropical Medicine and International Health 8: 336–41.12667153)
Sudha G, Nirupa C, Rajasakthivel M et al. 2003. Factors influencing the care-seeking behaviour of chest symptomatics: a community-based study involving rural and urban population in Tamil Nadu, South India. Tropical Medicine and International Health 8: 336–41.12667153Sudha G, Nirupa C, Rajasakthivel M et al. 2003. Factors influencing the care-seeking behaviour of chest symptomatics: a community-based study involving rural and urban population in Tamil Nadu, South India. Tropical Medicine and International Health 8: 336–41.12667153, Sudha G, Nirupa C, Rajasakthivel M et al. 2003. Factors influencing the care-seeking behaviour of chest symptomatics: a community-based study involving rural and urban population in Tamil Nadu, South India. Tropical Medicine and International Health 8: 336–41.12667153
N. Lurie, G. Keusch, V. Dzau (2021)
Urgent lessons from COVID 19: why the world needs a standing, coordinated system and sustainable financing for global research and developmentLancet (London, England), 397
Surendra Sharma, K. Dheda (2019)
What is new in the WHO consolidated guidelines on drug-resistant tuberculosis treatment?The Indian Journal of Medical Research, 149
J Ho, AL Byrne, NN Linh (2017)
Decentralized care for multidrug-resistant tuberculosis: a systematic review and meta-analysis, 95
( Abbas S, Kermode M, Kane S. 2021. Strengthening the response to drug-resistant TB in Pakistan: a practice theory-informed approach. Public Health Action 10: 147–56.)
Abbas S, Kermode M, Kane S. 2021. Strengthening the response to drug-resistant TB in Pakistan: a practice theory-informed approach. Public Health Action 10: 147–56.Abbas S, Kermode M, Kane S. 2021. Strengthening the response to drug-resistant TB in Pakistan: a practice theory-informed approach. Public Health Action 10: 147–56., Abbas S, Kermode M, Kane S. 2021. Strengthening the response to drug-resistant TB in Pakistan: a practice theory-informed approach. Public Health Action 10: 147–56.
( Ketema DB, Muchie KF, Andargie AA. 2019. Time to poor treatment outcome and its predictors among drug-resistant tuberculosis patients on second-line anti-Tuberculosis treatment in Amhara region, Ethiopia: retrospective cohort study. BMC Public Health 19: 1481.)
Ketema DB, Muchie KF, Andargie AA. 2019. Time to poor treatment outcome and its predictors among drug-resistant tuberculosis patients on second-line anti-Tuberculosis treatment in Amhara region, Ethiopia: retrospective cohort study. BMC Public Health 19: 1481.Ketema DB, Muchie KF, Andargie AA. 2019. Time to poor treatment outcome and its predictors among drug-resistant tuberculosis patients on second-line anti-Tuberculosis treatment in Amhara region, Ethiopia: retrospective cohort study. BMC Public Health 19: 1481., Ketema DB, Muchie KF, Andargie AA. 2019. Time to poor treatment outcome and its predictors among drug-resistant tuberculosis patients on second-line anti-Tuberculosis treatment in Amhara region, Ethiopia: retrospective cohort study. BMC Public Health 19: 1481.
( Alpert JL et al. 2020. Annual primary care 2030 convening: creating an enabling ecosystem for person-centered primary healthcare models to achieve universal health coverage in low-and middle-income countries. Annals of Global Health 86: 1–6.31934549)
Alpert JL et al. 2020. Annual primary care 2030 convening: creating an enabling ecosystem for person-centered primary healthcare models to achieve universal health coverage in low-and middle-income countries. Annals of Global Health 86: 1–6.31934549Alpert JL et al. 2020. Annual primary care 2030 convening: creating an enabling ecosystem for person-centered primary healthcare models to achieve universal health coverage in low-and middle-income countries. Annals of Global Health 86: 1–6.31934549, Alpert JL et al. 2020. Annual primary care 2030 convening: creating an enabling ecosystem for person-centered primary healthcare models to achieve universal health coverage in low-and middle-income countries. Annals of Global Health 86: 1–6.31934549
( Gray AT, Boyles T, Luedtke S et al. 2020. A threat to decentralised care for drug-resistant tuberculosis. The Lancet Respiratory Medicine 8: 950–2.33007284)
Gray AT, Boyles T, Luedtke S et al. 2020. A threat to decentralised care for drug-resistant tuberculosis. The Lancet Respiratory Medicine 8: 950–2.33007284Gray AT, Boyles T, Luedtke S et al. 2020. A threat to decentralised care for drug-resistant tuberculosis. The Lancet Respiratory Medicine 8: 950–2.33007284, Gray AT, Boyles T, Luedtke S et al. 2020. A threat to decentralised care for drug-resistant tuberculosis. The Lancet Respiratory Medicine 8: 950–2.33007284
MF Franke, P Khan, C Hewison (2021)
Culture conversion in patients treated with bedaquiline and/or delamanid, 203
E. Ardizzoni, E. Fajardo, P. Saranchuk, M. Casenghi, A. Page, F. Varaine, C. Kosack, P. Hepple (2015)
Implementing the Xpert® MTB/RIF Diagnostic Test for Tuberculosis and Rifampicin Resistance: Outcomes and Lessons Learned in 18 CountriesPLoS ONE, 10
M. Mushtaq, Ubeera Shahid, H. Abdullah, Anum Saeed, F. Omer, M. Shad, A. Siddiqui, J. Akram (2011)
Urban-rural inequities in knowledge, attitudes and practices regarding tuberculosis in two districts of Pakistan's Punjab provinceInternational Journal for Equity in Health, 10
L. Gabbasova, E. Who (2014)
Global tuberculosis report (2014)
( Iqbal F, Defer MK, Latif A et al. 2020. Understanding how geographic, demographic and treatment history impact health outcomes of patients with multi-drug-resistant tuberculosis in Pakistan, 2014–2017. Epidemiology and Infection 148: e253.)
Iqbal F, Defer MK, Latif A et al. 2020. Understanding how geographic, demographic and treatment history impact health outcomes of patients with multi-drug-resistant tuberculosis in Pakistan, 2014–2017. Epidemiology and Infection 148: e253.Iqbal F, Defer MK, Latif A et al. 2020. Understanding how geographic, demographic and treatment history impact health outcomes of patients with multi-drug-resistant tuberculosis in Pakistan, 2014–2017. Epidemiology and Infection 148: e253., Iqbal F, Defer MK, Latif A et al. 2020. Understanding how geographic, demographic and treatment history impact health outcomes of patients with multi-drug-resistant tuberculosis in Pakistan, 2014–2017. Epidemiology and Infection 148: e253.
( Lyakurwa D, Lyimo J, Mulder C et al. 2021. Assessment of training and mentoring for DR-TB care decentralization in Tanzania. Human Resources for Health 19: 56.)
Lyakurwa D, Lyimo J, Mulder C et al. 2021. Assessment of training and mentoring for DR-TB care decentralization in Tanzania. Human Resources for Health 19: 56.Lyakurwa D, Lyimo J, Mulder C et al. 2021. Assessment of training and mentoring for DR-TB care decentralization in Tanzania. Human Resources for Health 19: 56., Lyakurwa D, Lyimo J, Mulder C et al. 2021. Assessment of training and mentoring for DR-TB care decentralization in Tanzania. Human Resources for Health 19: 56.
C Jackson, HR Stagg, A Doshi (2017)
Tuberculosis treatment outcomes among disadvantaged patients in India, 7
P. Lloyd-Sherlock, S. Ebrahim, L. Geffen, M. Mckee (2020)
Bearing the brunt of covid-19: older people in low and middle income countriesBMJ, 368
Clemma Muller, R. MacLehose (2014)
Estimating predicted probabilities from logistic regression: different methods correspond to different target populations.International journal of epidemiology, 43 3
( Furin J, Brigden G, Lessem E et al. 2016. Global progress and challenges in implementing new medications for treating multidrug-resistant tuberculosis. Emerging Infectious Diseases 22: 3.)
Furin J, Brigden G, Lessem E et al. 2016. Global progress and challenges in implementing new medications for treating multidrug-resistant tuberculosis. Emerging Infectious Diseases 22: 3.Furin J, Brigden G, Lessem E et al. 2016. Global progress and challenges in implementing new medications for treating multidrug-resistant tuberculosis. Emerging Infectious Diseases 22: 3., Furin J, Brigden G, Lessem E et al. 2016. Global progress and challenges in implementing new medications for treating multidrug-resistant tuberculosis. Emerging Infectious Diseases 22: 3.
J. Hughes, L. Snyman (2018)
Palliative care for drug-resistant tuberculosis: when new drugs are not enough.The Lancet. Respiratory medicine, 6 4
( De Vries G, Tsolova S, Anderson LF et al. 2017. Health system factors influencing management of multidrug-resistant tuberculosis in four European Union countries - learning from country experiences. BMC Public Health 17: 334.)
De Vries G, Tsolova S, Anderson LF et al. 2017. Health system factors influencing management of multidrug-resistant tuberculosis in four European Union countries - learning from country experiences. BMC Public Health 17: 334.De Vries G, Tsolova S, Anderson LF et al. 2017. Health system factors influencing management of multidrug-resistant tuberculosis in four European Union countries - learning from country experiences. BMC Public Health 17: 334., De Vries G, Tsolova S, Anderson LF et al. 2017. Health system factors influencing management of multidrug-resistant tuberculosis in four European Union countries - learning from country experiences. BMC Public Health 17: 334.
( Furin J, Loveday M, Hlangu S et al. 2020. “A very humiliating illness”: a qualitative study of patient-centered Care for Rifampicin-Resistant Tuberculosis in South Africa. BMC Public Health 20: 76.)
Furin J, Loveday M, Hlangu S et al. 2020. “A very humiliating illness”: a qualitative study of patient-centered Care for Rifampicin-Resistant Tuberculosis in South Africa. BMC Public Health 20: 76.Furin J, Loveday M, Hlangu S et al. 2020. “A very humiliating illness”: a qualitative study of patient-centered Care for Rifampicin-Resistant Tuberculosis in South Africa. BMC Public Health 20: 76., Furin J, Loveday M, Hlangu S et al. 2020. “A very humiliating illness”: a qualitative study of patient-centered Care for Rifampicin-Resistant Tuberculosis in South Africa. BMC Public Health 20: 76.
G. Sudha, C. Nirupa, M. Rajasakthivel, S. Sivasusbramanian, V. Sundaram, S. Bhatt, K. Subramaniam, E. Thiruvalluvan, R. Mathew, G. Renu, T. Sántha (2003)
Factors influencing the care‐seeking behaviour of chest symptomatics: a community‐based study involving rural and urban population in Tamil Nadu, South IndiaTropical Medicine & International Health, 8
G. Vries, S. Tsolova, L. Anderson, A. Gebhard, E. Heldal, V. Hollo, L. Cejudo, D. Schmid, B. Schreuder, T. Varleva, M. Werf (2017)
Health system factors influencing management of multidrug-resistant tuberculosis in four European Union countries - learning from country experiencesBMC Public Health, 17
Keri Geiger, A. Bergman, J. Farley (2021)
Evaluating Integrated Care for People Living With HIV and Multidrug-Resistant Tuberculosis in South Africa: A Case-Based Approach Using the Chronic Care ModelJournal of the Association of Nurses in AIDS Care, 32
Jessica Alpert, Sofiat Akinola, Edward Booty, D. Dimitrova, T. Do, Audu Emmanuel, Pascal Fröhlicher, Caroline Gitonga, Phan Hang, L. Hunt, S. Hussein, Helen Kiarie, Sejal Mistry, R. Ngechu, I. Nikolic, Agatha Olago, T. Pollack, Ruben Vellenga, Bram Wispelwey, D. Duong (2020)
Annual Primary Care 2030 Convening: Creating an Enabling Ecosystem for Person-Centered Primary Healthcare Models to Achieve Universal Health Coverage in Low- and Middle-Income CountriesAnnals of Global Health, 86
( Cambanis A, Yassin MA, Ramsay A et al. 2005. Rural poverty and delayed presentation to tuberculosis services in Ethiopia. Tropical Medicine and International Health 10: 330–5.15807796)
Cambanis A, Yassin MA, Ramsay A et al. 2005. Rural poverty and delayed presentation to tuberculosis services in Ethiopia. Tropical Medicine and International Health 10: 330–5.15807796Cambanis A, Yassin MA, Ramsay A et al. 2005. Rural poverty and delayed presentation to tuberculosis services in Ethiopia. Tropical Medicine and International Health 10: 330–5.15807796, Cambanis A, Yassin MA, Ramsay A et al. 2005. Rural poverty and delayed presentation to tuberculosis services in Ethiopia. Tropical Medicine and International Health 10: 330–5.15807796
( Mushtaq MU, Shahid U, Abdullah HM et al. 2011. Urban-rural inequities in knowledge, attitudes and practices regarding tuberculosis in two districts of Pakistan’s Punjab province. International Journal for Equity in Health 10: 8.)
Mushtaq MU, Shahid U, Abdullah HM et al. 2011. Urban-rural inequities in knowledge, attitudes and practices regarding tuberculosis in two districts of Pakistan’s Punjab province. International Journal for Equity in Health 10: 8.Mushtaq MU, Shahid U, Abdullah HM et al. 2011. Urban-rural inequities in knowledge, attitudes and practices regarding tuberculosis in two districts of Pakistan’s Punjab province. International Journal for Equity in Health 10: 8., Mushtaq MU, Shahid U, Abdullah HM et al. 2011. Urban-rural inequities in knowledge, attitudes and practices regarding tuberculosis in two districts of Pakistan’s Punjab province. International Journal for Equity in Health 10: 8.
Dennis Lyakurwa, J. Lyimo, C. Mulder, P. Pelzer, Inge Koppelaar, M. Heus (2021)
Assessment of training and mentoring for DR-TB care decentralization in TanzaniaHuman Resources for Health, 19
( Muller CJ, Maclehose RF. 2014. Estimating predicted probabilities from logistic regression: different methods correspond to different target populations. International Journal of Epidemiology 43: 962–70.24603316)
Muller CJ, Maclehose RF. 2014. Estimating predicted probabilities from logistic regression: different methods correspond to different target populations. International Journal of Epidemiology 43: 962–70.24603316Muller CJ, Maclehose RF. 2014. Estimating predicted probabilities from logistic regression: different methods correspond to different target populations. International Journal of Epidemiology 43: 962–70.24603316, Muller CJ, Maclehose RF. 2014. Estimating predicted probabilities from logistic regression: different methods correspond to different target populations. International Journal of Epidemiology 43: 962–70.24603316
( Brokamp C, Wolfe C, Lingren T et al. 2018. Decentralized and reproducible geocoding and characterization of community and environmental exposures for multisite studies. Journal of the American Medical Informatics Association 25: 309–14.29126118)
Brokamp C, Wolfe C, Lingren T et al. 2018. Decentralized and reproducible geocoding and characterization of community and environmental exposures for multisite studies. Journal of the American Medical Informatics Association 25: 309–14.29126118Brokamp C, Wolfe C, Lingren T et al. 2018. Decentralized and reproducible geocoding and characterization of community and environmental exposures for multisite studies. Journal of the American Medical Informatics Association 25: 309–14.29126118, Brokamp C, Wolfe C, Lingren T et al. 2018. Decentralized and reproducible geocoding and characterization of community and environmental exposures for multisite studies. Journal of the American Medical Informatics Association 25: 309–14.29126118
M. Khan, A. Meghani, Marco Liverani, Imara Roychowdhury, J. Parkhurst (2017)
How do external donors influence national health policy processes? Experiences of domestic policy actors in Cambodia and PakistanHealth Policy and Planning, 33
J. Furin, G. Brigden, E. Lessem, Michael Rich, Laura Vaughan, S. Lynch (2016)
Global Progress and Challenges in Implementing New Medications for Treating Multidrug-Resistant TuberculosisEmerging Infectious Diseases, 22
(1954)
THE WORLD HEALTH ORGANIZATIONMedical Journal of Australia, 2
S. Leavitt, K. Jacobson, E. Ragan, J. Bor, J. Hughes, T. Bouton, T. Dolby, R. Warren, H. Jenkins (2021)
Decentralized Care for Rifampin-Resistant Tuberculosis, Western Cape, South AfricaEmerging Infectious Diseases, 27
( Leavitt SV, Jacobson KR, Ragan EJ et al. 2021. Decentralized care for rifampin-resistant tuberculosis, Western Cape, South Africa. Emerging Infectious Diseases 27: 728–39.33622466)
Leavitt SV, Jacobson KR, Ragan EJ et al. 2021. Decentralized care for rifampin-resistant tuberculosis, Western Cape, South Africa. Emerging Infectious Diseases 27: 728–39.33622466Leavitt SV, Jacobson KR, Ragan EJ et al. 2021. Decentralized care for rifampin-resistant tuberculosis, Western Cape, South Africa. Emerging Infectious Diseases 27: 728–39.33622466, Leavitt SV, Jacobson KR, Ragan EJ et al. 2021. Decentralized care for rifampin-resistant tuberculosis, Western Cape, South Africa. Emerging Infectious Diseases 27: 728–39.33622466
L. Vanleeuw, S. Atkins, W. Zembe-Mkabile, M. Loveday (2020)
Provider perspectives of the introduction and implementation of care for drug-resistant tuberculosis patients in district-level facilities in South Africa: a qualitative studyBMJ Open, 10
( Norton EC, Miller MM, Kleinman LC. 2013. Computing adjusted risk ratios and risk differences in Stata. The Stata Journal: Promoting Communications on Statistics and Stata 13: 492–509.)
Norton EC, Miller MM, Kleinman LC. 2013. Computing adjusted risk ratios and risk differences in Stata. The Stata Journal: Promoting Communications on Statistics and Stata 13: 492–509.Norton EC, Miller MM, Kleinman LC. 2013. Computing adjusted risk ratios and risk differences in Stata. The Stata Journal: Promoting Communications on Statistics and Stata 13: 492–509., Norton EC, Miller MM, Kleinman LC. 2013. Computing adjusted risk ratios and risk differences in Stata. The Stata Journal: Promoting Communications on Statistics and Stata 13: 492–509.
(2021b)
The Directions API overview
( Vanleeuw L, Atkins S, Zembe-Mkabile W et al. 2020. Provider perspectives of the introduction and implementation of care for drug-resistant tuberculosis patients in district-level facilities in South Africa: a qualitative study. BMJ Open 10: e032591.)
Vanleeuw L, Atkins S, Zembe-Mkabile W et al. 2020. Provider perspectives of the introduction and implementation of care for drug-resistant tuberculosis patients in district-level facilities in South Africa: a qualitative study. BMJ Open 10: e032591.Vanleeuw L, Atkins S, Zembe-Mkabile W et al. 2020. Provider perspectives of the introduction and implementation of care for drug-resistant tuberculosis patients in district-level facilities in South Africa: a qualitative study. BMJ Open 10: e032591., Vanleeuw L, Atkins S, Zembe-Mkabile W et al. 2020. Provider perspectives of the introduction and implementation of care for drug-resistant tuberculosis patients in district-level facilities in South Africa: a qualitative study. BMJ Open 10: e032591.
M. Franke, P. Khan, C. Hewison, U. Khan, H. Huerga, K. Seung, M. Rich, K. Zarli, N. Samieva, L. Oyewusi, P. Nair, M. Mudassar, N. Melikyan, P. Lenggogeni, L. Lecca, A. Kumsa, Munira Khan, S. Islam, K. Hussein, W. Docteur, N. Chumburidze, E. Berikova, H. Atshemyan, S. Atwood, M. Alam, Saman Ahmed, M. Bastard (2020)
Culture Conversion in Patients Treated with Bedaquiline and/or Delamanid. A Prospective Multicountry StudyAmerican Journal of Respiratory and Critical Care Medicine, 203
A. Byrne, B. Marais, C. Mitnick, F. Garden, L. Lecca, C. Contreras, Y. Yauri, F. García, G. Marks (2018)
Feasibility and yield of screening for non-communicable diseases among treated tuberculosis patients in Peru.The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, 22 1
P. Daru, R. Matji, H. Almossawi, K. Chakraborty, N. Kak (2018)
Decentralized, Community-Based Treatment for Drug-Resistant Tuberculosis: Bangladesh Program ExperienceGlobal Health: Science and Practice, 6
M. Yassin (2005)
Diagnosis of tuberculosis in developing countries in the era of high HIV transmission; alternative approaches
P. Ehrenkranz, A. Grimsrud, C. Holmes, P. Preko, M. Rabkin (2020)
Expanding the Vision for Differentiated Service Delivery: A Call for More Inclusive and Truly Patient-Centered Care for People Living With HIVJournal of Acquired Immune Deficiency Syndromes (1999), 86
( Mbuthia GW, Olungah CO, Ondicho TG, Fair E. 2018. Health-seeking pathway and factors leading to delays in tuberculosis diagnosis in West Pokot County, Kenya: a grounded theory study. PLoS One 13: e0207995.)
Mbuthia GW, Olungah CO, Ondicho TG, Fair E. 2018. Health-seeking pathway and factors leading to delays in tuberculosis diagnosis in West Pokot County, Kenya: a grounded theory study. PLoS One 13: e0207995.Mbuthia GW, Olungah CO, Ondicho TG, Fair E. 2018. Health-seeking pathway and factors leading to delays in tuberculosis diagnosis in West Pokot County, Kenya: a grounded theory study. PLoS One 13: e0207995., Mbuthia GW, Olungah CO, Ondicho TG, Fair E. 2018. Health-seeking pathway and factors leading to delays in tuberculosis diagnosis in West Pokot County, Kenya: a grounded theory study. PLoS One 13: e0207995.
C. Brokamp, C. Wolfe, T. Lingren, J. Harley, P. Ryan (2017)
Decentralized and reproducible geocoding and characterization of community and environmental exposures for multisite studiesJournal of the American Medical Informatics Association : JAMIA, 25
D. Ketema, Kindie Muchie, Asrat Andargie (2019)
Time to poor treatment outcome and its predictors among drug-resistant tuberculosis patients on second-line anti-tuberculosis treatment in Amhara region, Ethiopia: retrospective cohort studyBMC Public Health, 19
C. Rensburg, R. Berhanu, K. Hirasen, D. Evans, S. Rosen, L. Long (2019)
Cost outcome analysis of decentralized care for drug-resistant tuberculosis in Johannesburg, South AfricaPLoS ONE, 14
( Ehrenkranz P, Grimsrud A, Holmes CB et al. 2021. Expanding the vision for differentiated service delivery: a call for more inclusive and truly patient-centered care for people living with HIV. Journal of Acquired Immune Deficiency Syndromes (1999) 86: 147–52.33136818)
Ehrenkranz P, Grimsrud A, Holmes CB et al. 2021. Expanding the vision for differentiated service delivery: a call for more inclusive and truly patient-centered care for people living with HIV. Journal of Acquired Immune Deficiency Syndromes (1999) 86: 147–52.33136818Ehrenkranz P, Grimsrud A, Holmes CB et al. 2021. Expanding the vision for differentiated service delivery: a call for more inclusive and truly patient-centered care for people living with HIV. Journal of Acquired Immune Deficiency Syndromes (1999) 86: 147–52.33136818, Ehrenkranz P, Grimsrud A, Holmes CB et al. 2021. Expanding the vision for differentiated service delivery: a call for more inclusive and truly patient-centered care for people living with HIV. Journal of Acquired Immune Deficiency Syndromes (1999) 86: 147–52.33136818
( Khan U, Huerga H, Khan AJ et al. 2019. The endTB observational study protocol: treatment of MDR-TB with bedaquiline or delamanid containing regimens. BMC Infectious Diseases 19: 733.)
Khan U, Huerga H, Khan AJ et al. 2019. The endTB observational study protocol: treatment of MDR-TB with bedaquiline or delamanid containing regimens. BMC Infectious Diseases 19: 733.Khan U, Huerga H, Khan AJ et al. 2019. The endTB observational study protocol: treatment of MDR-TB with bedaquiline or delamanid containing regimens. BMC Infectious Diseases 19: 733., Khan U, Huerga H, Khan AJ et al. 2019. The endTB observational study protocol: treatment of MDR-TB with bedaquiline or delamanid containing regimens. BMC Infectious Diseases 19: 733.
J. Furin, M. Loveday, S. Hlangu, L. Dickson-Hall, S. Roux, M. Nicol, H. Cox (2020)
“A very humiliating illness”: a qualitative study of patient-centered Care for Rifampicin-Resistant Tuberculosis in South AfricaBMC Public Health, 20
( Byrne AL et al. 2018. Feasibility and yield of screening for non-communicable diseases among treated tuberculosis patients in Peru. International Journal of Tuberculosis and Lung Disease 22: 86–92.)
Byrne AL et al. 2018. Feasibility and yield of screening for non-communicable diseases among treated tuberculosis patients in Peru. International Journal of Tuberculosis and Lung Disease 22: 86–92.Byrne AL et al. 2018. Feasibility and yield of screening for non-communicable diseases among treated tuberculosis patients in Peru. International Journal of Tuberculosis and Lung Disease 22: 86–92., Byrne AL et al. 2018. Feasibility and yield of screening for non-communicable diseases among treated tuberculosis patients in Peru. International Journal of Tuberculosis and Lung Disease 22: 86–92.
Charlotte Jackson, H. Stagg, A. Doshi, D. Pan, A. Sinha, R. Batra, S. Batra, I. Abubakar, M. Lipman (2017)
Public Health Action International Union Against Tuberculosis and Lung Disease Health solutions for the poor
E. Norton, Morgen Miller, L. Kleinman (2013)
Computing Adjusted Risk Ratios and Risk Differences in StataThe Stata Journal, 13
A Cambanis, MA Yassin, A Ramsay (2005)
Rural poverty and delayed presentation to tuberculosis services in Ethiopia, 10
F. Iqbal, M. Defer, A. Latif, H. Hadi (2020)
Understanding how geographic, demographic and treatment history impact health outcomes of patients with multi-drug-resistant tuberculosis in Pakistan, 2014–2017Epidemiology and Infection, 148
(2013)
WHO revised definitions and reporting framework for tuberculosis.Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, 18 16
( Lurie N, Keusch GT, Dzau VJ. 2021. Urgent lessons from COVID 19: why the world needs a standing, coordinated system and sustainable financing for global research and development. The Lancet 397: 1229–36.)
Lurie N, Keusch GT, Dzau VJ. 2021. Urgent lessons from COVID 19: why the world needs a standing, coordinated system and sustainable financing for global research and development. The Lancet 397: 1229–36.Lurie N, Keusch GT, Dzau VJ. 2021. Urgent lessons from COVID 19: why the world needs a standing, coordinated system and sustainable financing for global research and development. The Lancet 397: 1229–36., Lurie N, Keusch GT, Dzau VJ. 2021. Urgent lessons from COVID 19: why the world needs a standing, coordinated system and sustainable financing for global research and development. The Lancet 397: 1229–36.
(2016)
Psychosocio-economic issues challenging multidrug resistant tuberculosis patients: a systematic review
( World Health Organization . 2019. WHO Consolidated Guidelines on Drug-resistant Tuberculosis Treatment. Geneva: World Health Organization. Indian Journal of Medical Research.doi: 10.4103/ijmr.IJMR_579_19.)
World Health Organization . 2019. WHO Consolidated Guidelines on Drug-resistant Tuberculosis Treatment. Geneva: World Health Organization. Indian Journal of Medical Research.doi: 10.4103/ijmr.IJMR_579_19.World Health Organization . 2019. WHO Consolidated Guidelines on Drug-resistant Tuberculosis Treatment. Geneva: World Health Organization. Indian Journal of Medical Research.doi: 10.4103/ijmr.IJMR_579_19., World Health Organization . 2019. WHO Consolidated Guidelines on Drug-resistant Tuberculosis Treatment. Geneva: World Health Organization. Indian Journal of Medical Research.doi: 10.4103/ijmr.IJMR_579_19.
M. Scheffer, R. Prim, L. Wildner, Taiane Medeiros, Rosemeri Maurici, E. Kupek, M. Bazzo (2018)
Performance of centralized versus decentralized tuberculosis treatment services in Southern Brazil, 2006–2015BMC Public Health, 18
G. Craig, A. Daftary, N. Engel, S. O'driscoll, A. Ioannaki (2017)
Tuberculosis stigma as a social determinant of health: a systematic mapping review of research in low incidence countries.International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 56
C. Vieira, O. Franco, C. Restrepo, T. Abel (2020)
COVID-19: The forgotten priorities of the pandemicMaturitas, 136
G. Calligaro, Zani Wit, J. Cirota, C. Orrell, B. Myers, S. Decker, Dan Stein, K. Sorsdahl, R. Dawson (2020)
Brief psychotherapy administered by non-specialised health workers to address risky substance use in patients with multidrug-resistant tuberculosis: a feasibility and acceptability studyPilot and Feasibility Studies, 7
( Ho J, Byrne AL, Linh NN et al. 2017. Decentralized care for multidrug-resistant tuberculosis: a systematic review and meta-analysis. Bulletin of the World Health Organization 95: 584–93.28804170)
Ho J, Byrne AL, Linh NN et al. 2017. Decentralized care for multidrug-resistant tuberculosis: a systematic review and meta-analysis. Bulletin of the World Health Organization 95: 584–93.28804170Ho J, Byrne AL, Linh NN et al. 2017. Decentralized care for multidrug-resistant tuberculosis: a systematic review and meta-analysis. Bulletin of the World Health Organization 95: 584–93.28804170, Ho J, Byrne AL, Linh NN et al. 2017. Decentralized care for multidrug-resistant tuberculosis: a systematic review and meta-analysis. Bulletin of the World Health Organization 95: 584–93.28804170
( Jackson C, Stagg HR, Doshi A et al. 2017. Tuberculosis treatment outcomes among disadvantaged patients in India. Public Health Action 7: 134–40.28695087)
Jackson C, Stagg HR, Doshi A et al. 2017. Tuberculosis treatment outcomes among disadvantaged patients in India. Public Health Action 7: 134–40.28695087Jackson C, Stagg HR, Doshi A et al. 2017. Tuberculosis treatment outcomes among disadvantaged patients in India. Public Health Action 7: 134–40.28695087, Jackson C, Stagg HR, Doshi A et al. 2017. Tuberculosis treatment outcomes among disadvantaged patients in India. Public Health Action 7: 134–40.28695087
U. Khan, H. Huerga, A. Khan, C. Mitnick, C. Hewison, F. Varaine, M. Bastard, Michael Rich, M. Franke, S. Atwood, P. Khan, K. Seung (2019)
The endTB observational study protocol: treatment of MDR-TB with bedaquiline or delamanid containing regimensBMC Infectious Diseases, 19
D. Evans, T. Sineke, K. Schnippel, R. Berhanu, C. Govathson, A. Black, L. Long, S. Rosen (2018)
Impact of Xpert MTB/RIF and decentralized care on linkage to care and drug-resistant tuberculosis treatment outcomes in Johannesburg, South AfricaBMC Health Services Research, 18
( Geiger K, Bergman A, Farley JE. 2021. Evaluating integrated care for people living with HIV and multidrug-resistant tuberculosis in South Africa: a case-based approach using the chronic care model. Journal of the Association of Nurses in AIDS Care 32: e91–102.)
Geiger K, Bergman A, Farley JE. 2021. Evaluating integrated care for people living with HIV and multidrug-resistant tuberculosis in South Africa: a case-based approach using the chronic care model. Journal of the Association of Nurses in AIDS Care 32: e91–102.Geiger K, Bergman A, Farley JE. 2021. Evaluating integrated care for people living with HIV and multidrug-resistant tuberculosis in South Africa: a case-based approach using the chronic care model. Journal of the Association of Nurses in AIDS Care 32: e91–102., Geiger K, Bergman A, Farley JE. 2021. Evaluating integrated care for people living with HIV and multidrug-resistant tuberculosis in South Africa: a case-based approach using the chronic care model. Journal of the Association of Nurses in AIDS Care 32: e91–102.
G. Mbuthia, C. Olungah, T. Ondicho (2018)
Health-seeking pathway and factors leading to delays in tuberculosis diagnosis in West Pokot County, Kenya: A grounded theory studyPLoS ONE, 13
( Sigfrid L, Maskell K, Bannister PG et al. 2020. Addressing challenges for clinical research responses to emerging epidemics and pandemics: a scoping review. BMC Medicine 18: 190.)
Sigfrid L, Maskell K, Bannister PG et al. 2020. Addressing challenges for clinical research responses to emerging epidemics and pandemics: a scoping review. BMC Medicine 18: 190.Sigfrid L, Maskell K, Bannister PG et al. 2020. Addressing challenges for clinical research responses to emerging epidemics and pandemics: a scoping review. BMC Medicine 18: 190., Sigfrid L, Maskell K, Bannister PG et al. 2020. Addressing challenges for clinical research responses to emerging epidemics and pandemics: a scoping review. BMC Medicine 18: 190.
( Cox V, Cox H, Pai M et al. 2019. Health care gaps in the global burden of drug-resistant tuberculosis. The International Journal of Tuberculosis and Lung Disease: The Official Journal of the International Union against Tuberculosis and Lung Disease 23: 125–35.)
Cox V, Cox H, Pai M et al. 2019. Health care gaps in the global burden of drug-resistant tuberculosis. The International Journal of Tuberculosis and Lung Disease: The Official Journal of the International Union against Tuberculosis and Lung Disease 23: 125–35.Cox V, Cox H, Pai M et al. 2019. Health care gaps in the global burden of drug-resistant tuberculosis. The International Journal of Tuberculosis and Lung Disease: The Official Journal of the International Union against Tuberculosis and Lung Disease 23: 125–35., Cox V, Cox H, Pai M et al. 2019. Health care gaps in the global burden of drug-resistant tuberculosis. The International Journal of Tuberculosis and Lung Disease: The Official Journal of the International Union against Tuberculosis and Lung Disease 23: 125–35.
( Craig GM, Daftary A, Engel N et al. 2017. Tuberculosis stigma as a social determinant of health: a systematic mapping review of research in low incidence countries. International Journal of Infectious Diseases 56: 90–100.27810521)
Craig GM, Daftary A, Engel N et al. 2017. Tuberculosis stigma as a social determinant of health: a systematic mapping review of research in low incidence countries. International Journal of Infectious Diseases 56: 90–100.27810521Craig GM, Daftary A, Engel N et al. 2017. Tuberculosis stigma as a social determinant of health: a systematic mapping review of research in low incidence countries. International Journal of Infectious Diseases 56: 90–100.27810521, Craig GM, Daftary A, Engel N et al. 2017. Tuberculosis stigma as a social determinant of health: a systematic mapping review of research in low incidence countries. International Journal of Infectious Diseases 56: 90–100.27810521
( Ardizzoni E, Fajardo E, Saranchuk P et al. 2015. Implementing the Xpert(R) MTB/RIF diagnostic test for tuberculosis and rifampicin resistance: outcomes and lessons learned in 18 countries. PLoS One 10: e0144656.)
Ardizzoni E, Fajardo E, Saranchuk P et al. 2015. Implementing the Xpert(R) MTB/RIF diagnostic test for tuberculosis and rifampicin resistance: outcomes and lessons learned in 18 countries. PLoS One 10: e0144656.Ardizzoni E, Fajardo E, Saranchuk P et al. 2015. Implementing the Xpert(R) MTB/RIF diagnostic test for tuberculosis and rifampicin resistance: outcomes and lessons learned in 18 countries. PLoS One 10: e0144656., Ardizzoni E, Fajardo E, Saranchuk P et al. 2015. Implementing the Xpert(R) MTB/RIF diagnostic test for tuberculosis and rifampicin resistance: outcomes and lessons learned in 18 countries. PLoS One 10: e0144656.
(2021)
Geocoding API Overview, Google Maps Platform
( Google Inc . 2021b. The Directions API overview, Google Maps Platform. https://developers.google.com/maps/documentation/directions/overview, accessed 29 April 2021.)
Google Inc . 2021b. The Directions API overview, Google Maps Platform. https://developers.google.com/maps/documentation/directions/overview, accessed 29 April 2021.Google Inc . 2021b. The Directions API overview, Google Maps Platform. https://developers.google.com/maps/documentation/directions/overview, accessed 29 April 2021., Google Inc . 2021b. The Directions API overview, Google Maps Platform. https://developers.google.com/maps/documentation/directions/overview, accessed 29 April 2021.
V. Cox, H. Cox, M. Pai, J. Stillo, B. Citro, G. Brigden (2019)
Health care gaps in the global burden of drug-resistant tuberculosis.The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, 23 2
( Mezwa K, McAnaw S, Chiang C-Y et al. 2018. Insights into drug-resistant tuberculosis treatment: results of The Union DR-TB Working Group Survey, 2017. Public Health Action 8: 141–4.30271731)
Mezwa K, McAnaw S, Chiang C-Y et al. 2018. Insights into drug-resistant tuberculosis treatment: results of The Union DR-TB Working Group Survey, 2017. Public Health Action 8: 141–4.30271731Mezwa K, McAnaw S, Chiang C-Y et al. 2018. Insights into drug-resistant tuberculosis treatment: results of The Union DR-TB Working Group Survey, 2017. Public Health Action 8: 141–4.30271731, Mezwa K, McAnaw S, Chiang C-Y et al. 2018. Insights into drug-resistant tuberculosis treatment: results of The Union DR-TB Working Group Survey, 2017. Public Health Action 8: 141–4.30271731
L. Sigfrid, Katherine Maskell, P. Bannister, S. Ismail, Shelui Collinson, S. Regmi, Claire Blackmore, E. Harriss, Kajsa-Stina Longuere, N. Gobat, P. Horby, M. Clarke, G. Carson (2020)
Addressing challenges for clinical research responses to emerging epidemics and pandemics: a scoping reviewBMC Medicine, 18
( Zawedde-Muyanja S, Nakanwagi A, Dongo JP et al. 2018. Decentralisation of child tuberculosis services increases case finding and uptake of preventive therapy in Uganda. International Journal of Tuberculosis and Lung Disease 22: 1314–21.)
Zawedde-Muyanja S, Nakanwagi A, Dongo JP et al. 2018. Decentralisation of child tuberculosis services increases case finding and uptake of preventive therapy in Uganda. International Journal of Tuberculosis and Lung Disease 22: 1314–21.Zawedde-Muyanja S, Nakanwagi A, Dongo JP et al. 2018. Decentralisation of child tuberculosis services increases case finding and uptake of preventive therapy in Uganda. International Journal of Tuberculosis and Lung Disease 22: 1314–21., Zawedde-Muyanja S, Nakanwagi A, Dongo JP et al. 2018. Decentralisation of child tuberculosis services increases case finding and uptake of preventive therapy in Uganda. International Journal of Tuberculosis and Lung Disease 22: 1314–21.
( Evans D, Sineke T, Schnippel K et al. 2018. Impact of Xpert MTB/RIF and decentralized care on linkage to care and drug-resistant tuberculosis treatment outcomes in Johannesburg, South Africa. BMC Health Services Research 18: 973.)
Evans D, Sineke T, Schnippel K et al. 2018. Impact of Xpert MTB/RIF and decentralized care on linkage to care and drug-resistant tuberculosis treatment outcomes in Johannesburg, South Africa. BMC Health Services Research 18: 973.Evans D, Sineke T, Schnippel K et al. 2018. Impact of Xpert MTB/RIF and decentralized care on linkage to care and drug-resistant tuberculosis treatment outcomes in Johannesburg, South Africa. BMC Health Services Research 18: 973., Evans D, Sineke T, Schnippel K et al. 2018. Impact of Xpert MTB/RIF and decentralized care on linkage to care and drug-resistant tuberculosis treatment outcomes in Johannesburg, South Africa. BMC Health Services Research 18: 973.
( Van Rensburg C, Berhanu R, Hirasen K et al. 2019. Cost outcome analysis of decentralized care for drug-resistant tuberculosis in Johannesburg, South Africa. PLoS One 14: e0217820.)
Van Rensburg C, Berhanu R, Hirasen K et al. 2019. Cost outcome analysis of decentralized care for drug-resistant tuberculosis in Johannesburg, South Africa. PLoS One 14: e0217820.Van Rensburg C, Berhanu R, Hirasen K et al. 2019. Cost outcome analysis of decentralized care for drug-resistant tuberculosis in Johannesburg, South Africa. PLoS One 14: e0217820., Van Rensburg C, Berhanu R, Hirasen K et al. 2019. Cost outcome analysis of decentralized care for drug-resistant tuberculosis in Johannesburg, South Africa. PLoS One 14: e0217820.
( Scheffer MC, Prim RI, Wildner LM et al. 2018. Performance of centralized versus decentralized tuberculosis treatment services in Southern Brazil, 2006–2015. BMC Public Health 18: 554.)
Scheffer MC, Prim RI, Wildner LM et al. 2018. Performance of centralized versus decentralized tuberculosis treatment services in Southern Brazil, 2006–2015. BMC Public Health 18: 554.Scheffer MC, Prim RI, Wildner LM et al. 2018. Performance of centralized versus decentralized tuberculosis treatment services in Southern Brazil, 2006–2015. BMC Public Health 18: 554., Scheffer MC, Prim RI, Wildner LM et al. 2018. Performance of centralized versus decentralized tuberculosis treatment services in Southern Brazil, 2006–2015. BMC Public Health 18: 554.
( Lloyd-Sherlock P, Ebrahim S, Geffen L et al. 2020. Bearing the brunt of covid-19: older people in low and middle income countries. The BMJ 368: m1052.doi: 10.1136/bmj.m1052.)
Lloyd-Sherlock P, Ebrahim S, Geffen L et al. 2020. Bearing the brunt of covid-19: older people in low and middle income countries. The BMJ 368: m1052.doi: 10.1136/bmj.m1052.Lloyd-Sherlock P, Ebrahim S, Geffen L et al. 2020. Bearing the brunt of covid-19: older people in low and middle income countries. The BMJ 368: m1052.doi: 10.1136/bmj.m1052., Lloyd-Sherlock P, Ebrahim S, Geffen L et al. 2020. Bearing the brunt of covid-19: older people in low and middle income countries. The BMJ 368: m1052.doi: 10.1136/bmj.m1052.
K. Mezwa, S. McAnaw, C. Chiang, A. Trébucq, C. Horsburgh (2018)
Insights into drug-resistant tuberculosis treatment: results of The Union DR-TB Working Group Survey, 2017.Public health action, 8 3
G. Cutsem, P. Isaakidis, J. Farley, E. Nardell, G. Volchenkov, H. Cox (2016)
Infection Control for Drug-Resistant Tuberculosis: Early Diagnosis and Treatment Is the Key.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 62 Suppl 3
( Calligaro GL, de Wit Z, Cirota J et al. 2021. Brief psychotherapy administered by non-specialised health workers to address risky substance use in patients with multidrug-resistant tuberculosis: a feasibility and acceptability study. Pilot and Feasibility Studies 7: 28.)
Calligaro GL, de Wit Z, Cirota J et al. 2021. Brief psychotherapy administered by non-specialised health workers to address risky substance use in patients with multidrug-resistant tuberculosis: a feasibility and acceptability study. Pilot and Feasibility Studies 7: 28.Calligaro GL, de Wit Z, Cirota J et al. 2021. Brief psychotherapy administered by non-specialised health workers to address risky substance use in patients with multidrug-resistant tuberculosis: a feasibility and acceptability study. Pilot and Feasibility Studies 7: 28., Calligaro GL, de Wit Z, Cirota J et al. 2021. Brief psychotherapy administered by non-specialised health workers to address risky substance use in patients with multidrug-resistant tuberculosis: a feasibility and acceptability study. Pilot and Feasibility Studies 7: 28.
S. Zawedde-Muyanja, A. Nakanwagi, J. Dongo, M. Sekadde, R. Nyinoburyo, G. Ssentongo, A. Detjen, F. Mugabe, J. Nakawesi, Y. Karamagi, P. Amuge, Addy Kekitiinwa, S. Graham (2018)
Decentralisation of child tuberculosis services increases case finding and uptake of preventive therapy in Uganda.The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, 22 11
( Khan MS, Meghani A, Liverani M et al. 2018. How do external donors influence national health policy processes? Experiences of domestic policy actors in Cambodia and Pakistan. Health Policy and Planning 33: 215–23.29237026)
Khan MS, Meghani A, Liverani M et al. 2018. How do external donors influence national health policy processes? Experiences of domestic policy actors in Cambodia and Pakistan. Health Policy and Planning 33: 215–23.29237026Khan MS, Meghani A, Liverani M et al. 2018. How do external donors influence national health policy processes? Experiences of domestic policy actors in Cambodia and Pakistan. Health Policy and Planning 33: 215–23.29237026, Khan MS, Meghani A, Liverani M et al. 2018. How do external donors influence national health policy processes? Experiences of domestic policy actors in Cambodia and Pakistan. Health Policy and Planning 33: 215–23.29237026
( Mesa Vieira C, Franco OH, Gómez Restrepo C et al. 2020. COVID-19: the forgotten priorities of the pandemic. Maturitas 136: 38–41.32386664)
Mesa Vieira C, Franco OH, Gómez Restrepo C et al. 2020. COVID-19: the forgotten priorities of the pandemic. Maturitas 136: 38–41.32386664Mesa Vieira C, Franco OH, Gómez Restrepo C et al. 2020. COVID-19: the forgotten priorities of the pandemic. Maturitas 136: 38–41.32386664, Mesa Vieira C, Franco OH, Gómez Restrepo C et al. 2020. COVID-19: the forgotten priorities of the pandemic. Maturitas 136: 38–41.32386664
A. Gray, T. Boyles, Susanne Luedtke, B. Sossen, Georgiana Birjovanu, P. Kostkova, J. Hughes, H. Esmail (2020)
A threat to decentralised care for drug-resistant tuberculosisThe Lancet. Respiratory Medicine, 8
Decentralized, person-centred models of care delivery for drug-resistant tuberculosis (DR-TB) continue to be under-resourced in high-burden TB countries. The implementation of such models—made increasingly urgent by the COVID-19 pandemic—are key to addressing gaps in DR-TB care. We abstracted data of rifampicin-resistant (RR)/multidrug-resistant tuberculosis (MDR-TB) patients initiated on treatment at 11 facilities between 2010 and 2017 in Sindh and Balochistan provinces of Pakistan. We analysed trends in treatment outcomes relating to programme expansion to peri-urban and rural areas and estimated driving distance from patient residence to treatment facility. Among the 5586 RR/MDR-TB patients in the analysis, overall treatment success decreased from 82% to 66% between 2010 and 2017, as the programme expanded. The adjusted risk ratio for unfavourable outcomes was 1.013 (95% confidence interval 1.005–1.021) for every 20 km of driving distance. Our analysis suggests that expanding DR-TB care to centralized hubs added to increased unfavourable outcomes for people accessing care in peri-urban and rural districts. We propose that as enrolments increase, expanding DR-TB services close to or within affected communities is essential.
Health Policy and Planning – Oxford University Press
Published: May 9, 2022
Keywords: Tuberculosis; decentralization; community; health outcomes; lung disease; developing countries; geographical information systems; infectious diseases
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.